From Ironman to Advocate: Tom Hulsey’s Journey Through Prostate Cancer and Purpose
In this episode of OncTimes Talk, we chat with Tom Hulsey—athlete, author, and prostate cancer survivor—about the life-altering moment he re...
Radio and PodcastLive Radio & PodcastsScience & Medicine
Oncology Times - OT Broadcasts from the iPad Archives
Independent and targeted hematology/oncology news for cancer patient care team; breaking clinical news; oncology analysis and commentary; professional trends.
Episodes
20 of 200 episodesAccurate and Actionable: How Oncologists Get Fast, Comprehensive Therapeutic Insights from the OncoExTra® Test
In this third episode of the OncoExTra® podcast series, host Ruchika Talwar, MD, talks with Christy Russell, MD, Vice President of Medical A...
Empowering Cancer Care Through Movement: A Conversation with Sami Mansfield
In this episode of OncTimes Talk, we chat with Sami Mansfield, ACSM-CET, PN1, the founder of Cancer Wellness for Life, an organization dedic...
Defying the Odds: Katie Coleman's Journey from Diagnosis to Advocacy
In this episode of OncTimes Talk, we chat with Katie Coleman. Diagnosed with an ultra-rare stage IV kidney cancer in 2020 , her prognosis ha...
Making Comprehensive Genomic Profiling More Accurate for Everyone: The Importance of Patient-Matched Tumor-Normal Sequencing
In this podcast episode, host Ruchika Talwar, MD, is joined by Amin Mazloom, PhD, Senior Vice President of Bioinformatics, Biostatistics & D...
Transforming colorectal cancer management with tumor informed ctDNA testing
In this episode, Dr. Ruchika Talwar, a urologic oncologist at Vanderbilt University Medical Center, Dr. Adham Jurdi, a medical oncologist an...
Lessons in Resilience: Dr. Susan MacDonald's Healthcare Journey
In this episode of the OncTimes Talk, we chat with Susan MacDonald, MD, Associate Professor and Program Director of the Department of Urolog...
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities at High Risk
Masood Moghul, MBBS, a urologist and Research Fellow at the Royal Marsden Hospital and Institute of Cancer Research in London shared finding...
Striking Microbiome Bacterial Population Differences Distinguish Metastatic Prostate Cancer From Non-Metastatic Disease
At the 2025 ASCO Genitourinary Cancers Symposium, researchers from Japan reported marked differences between the populations of several key...
Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer
At the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, the Phase III AFU-GETUG-20 trial reported that adjuvant androgen deprivat...
Novel Score Selects Patients With Intermediate Risk Prostate Cancer Safe for Active Surveillance
A numerical formula called the absolute percentage pattern 4/5 (APP4) combining risk factors, including Gleason grade, PSA, and digital rect...
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities
Masood Moghul, MBBS, a urologist and research fellow at the Royal Marsden Hospital and Institute of Cancer Research in London, UK, discussed...
Episode 3, Better Informed Patient Journeys
In the third episode of A Deep Dive Into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speaking...
Episode 2, HRD Testing Deep-Dive
In the second episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speakin...
Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer
In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speaking...
KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma
The pivotal role of programmed death-ligand 1 (PD-L1) checkpoint inhibition for treating advanced melanoma has been confirmed in findings fr...
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
Although one in five colorectal cancers having microsatellite instability and expressing the Werner Helicase (WRN) gene could be treated wit...
Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development
A tumor-agnostic classifier and screening tool was announced at ESMO Congress 2024 in Barcelona. It was created to make it easier and quicke...
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
Findings from a study of patients receiving targeted therapy for their BRAFV600 mutation-positive advanced melanoma, suggest that switching...
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
The pivotal role of programmed death-ligand 1 (PD-L1) checkpoint inhibition for treating advanced melanoma has been confirmed in findings fr...